Liquidia Technologies is trading at $90.00 (+4.38%) in pre-market, appearing to move in tandem with a broader market recovery rather than company-specific news.

  • No specific regulatory updates, FDA headlines, or earnings reports were identified to account for the move.
  • The stock is likely tracking a wider "risk-on" sentiment, with the Nasdaq up 1.57% amid easing geopolitical tensions and lower oil prices.